Team Goemkarponn
PANAJI: The Food and Drugs Administration (FDA) of Madhya Pradesh has issued a critical warning regarding Coldrif Syrup (Batch No. SR-13), manufactured by M/s Sresan Pharmaceutical, following the tragic deaths of children in the state.
Samples of the syrup, which contains Paracetamol, Phenylephrine Hydrochloride, and Chlorpheniramine Maleate, were tested and found allegedly adulterated with Diethylene Glycol (DEG) at 46.28% w/v, a highly toxic substance. The batch in question was manufactured in May 2025 and has an expiry date of April 2027.
In response, the Office of the Controller, Food and Drugs Administration, Goa, has directed all chemists, pharmacies, distributors, and wholesalers to immediately stop sale or distribution of this batch and report any stocks to the Directorate without delay.
The public has also been urged to immediately stop using Coldrif Syrup, Batch No. SR-13, and report any possession to the FDA Goa at off-dfda.goa@nic.in. Authorities emphasize caution to prevent further risk to life.
This alert highlights the importance of vigilance in the pharmaceutical supply chain to prevent such tragic incidents.
